Michael Chiarella

Michael Chiarella has a diverse work experience in the pharmaceutical industry. Michael is currently working as a Senior Director of Clinical Science at Xencor since 2021. Prior to this, they served as the Vice President of Clinical Operations at Oncoceutics, Inc. from 2019 to 2021.

Before joining Oncoceutics, Inc., Chiarella was a Senior Director of Clinical Development at Jazz Pharmaceuticals from 2016 to 2019. In this role, they established relationships with Cooperative Groups in the US and EU, represented clinical development on clinical trial working groups, and participated in the preparation and submission of clinical sections and summaries for Vyxeos NDA.

From 2005 to 2016, Chiarella worked at Celator Pharmaceuticals as a Senior Director of Clinical Operations and Project Planning. Michael implemented and directed all aspects of solid tumor and hematology clinical programs, including development plan and protocol design, and was responsible for tracking clinical plans, timelines, and budgets.

Chiarella also served as an Associate Director of Clinical Center at Enzon Pharmaceuticals from 2003 to 2005. In this role, they directed the development of a pivotal phase investigational transplant drug, managed the overall budget and timeline, and responded to FDA queries.

Prior to that, Chiarella was the Director of Clinical Operations at Aton Pharma, Inc. from 2002 to 2003. Michael directed all clinical development projects, developed project plans and associated budgets and timelines.

Their career in the pharmaceutical industry started at PharmaNet, where they worked as a Director of Clinical Research from 1997 to 2002.

Overall, Chiarella's work experience spans various roles in clinical science, clinical operations, and project planning.

Michael Chiarella has a Bachelor of Science degree in Chemistry from Montclair State University. No specific start or end year for their education is provided.